AAAAAA
Results:
1-15
|
Results: 15
Authors:
KOHLER DR
MONTELLO MJ
GREEN L
HUNTLEY C
HIGH JL
FALLAVOLLITA A
GOLDSPIEL BR
Citation: Dr. Kohler et al., STANDARDIZING THE EXPRESSION AND NOMENCLATURE OF CANCER-TREATMENT REGIMENS, American journal of health-system pharmacy, 55(2), 1998, pp. 137-144
Authors:
GOLDSPIEL BR
Citation: Br. Goldspiel, CLINICAL OVERVIEW OF THE TAXANES, Pharmacotherapy, 17(5), 1997, pp. 110-125
Authors:
TOLCHER AW
COWAN KH
NOONE MH
DENICOFF AM
KOHLER DR
GOLDSPIEL BR
BARNES CS
MCCABE M
GOSSARD MR
ZUJEWSKI J
OSHAUGHNESSY JA
Citation: Aw. Tolcher et al., PHASE-I STUDY OF PACLITAXEL IN COMBINATION WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN METASTATIC BREAST-CANCER PATIENTS, Journal of clinical oncology, 14(1), 1996, pp. 95-102
Authors:
GOLDSPIEL BR
CURT GA
Citation: Br. Goldspiel et Ga. Curt, ISSUES IN ANTIEMETIC THERAPY, Cancer, 77(5), 1996, pp. 823-826
Authors:
WILSON WH
CHABNER BA
BRYANT G
BATES S
FOJO A
REGIS J
JAFFE ES
STEINBERG SM
GOLDSPIEL BR
CHESON BD
WITTES RE
Citation: Wh. Wilson et al., PHASE-II STUDY OF PACLITAXEL IN RELAPSED NON-HODGKINS-LYMPHOMAS, Journal of clinical oncology, 13(2), 1995, pp. 381-386
Authors:
BATES SE
MEADOWS B
GOLDSPIEL BR
DENICOFF A
LE TB
TUCKER E
STEINBERG SM
ELWOOD LJ
Citation: Se. Bates et al., A PILOT-STUDY OF AMIODARONE WITH INFUSIONAL DOXORUBICIN OR VINBLASTINE IN REFRACTORY BREAST-CANCER, Cancer chemotherapy and pharmacology, 35(6), 1995, pp. 457-463
Authors:
KOELLER JM
BURRIS HA
DORR RT
FINLEY RS
GOLDSPIEL BR
KUHN JG
ROWINSKY EK
Citation: Jm. Koeller et al., PHARMACEUTICAL ISSUES OF PACLITAXEL, The Annals of pharmacotherapy, 28(5), 1994, pp. 190000005-190000036
Authors:
WILSON WH
BERG SL
BRYANT G
WITTES RE
BATES S
FOJO A
STEINBERG SM
GOLDSPIEL BR
HERDT J
OSHAUGHNESSY J
BALIS FM
CHABNER BA
Citation: Wh. Wilson et al., PACLITAXEL IN DOXORUBICIN-REFRACTORY OR MITOXANTRONE-REFRACTORY BREAST-CANCER - A PHASE I II TRIAL OF 96-HOUR INFUSION/, Journal of clinical oncology, 12(8), 1994, pp. 1621-1629
Authors:
KOHLER DR
GOLDSPIEL BR
Citation: Dr. Kohler et Br. Goldspiel, PACLITAXEL (TAXOL), Pharmacotherapy, 14(1), 1994, pp. 3-34
Authors:
GOLDSPIEL BR
KOHLER DR
Citation: Br. Goldspiel et Dr. Kohler, ONDANSETRON AND METOCLOPRAMIDE FAIL TO PREVENT VOMITING SECONDARY TO ULTRA-HIGH-DOSE CISPLATIN-CARBOPLATIN CHEMOTHERAPY, Obstetrics and gynecology, 84(3), 1994, pp. 483-483
Authors:
KOELLER JA
FINLEY RS
GOLDSPIEL BR
LINDLEY CM
BALMER CM
BOURRET JA
DOZIER N
GREEN L
IGNOFFO RJ
SCOTT KA
SIEGEL J
Citation: Ja. Koeller et al., EXECUTIVE SUMMARY OF PETITION REQUESTING SPECIALTY RECOGNITION OF ONCOLOGY PHARMACY PRACTICE - TASK-FORCE ON SPECIALTY RECOGNITION OF ONCOLOGY PHARMACY PRACTICE, American journal of hospital pharmacy, 51(2), 1994, pp. 219-224
Authors:
PLUDA JM
SHAY LE
FOLI A
TANNENBAUM S
COHEN PJ
GOLDSPIEL BR
ADAMO D
COOPER MR
BRODER S
YARCHOAN R
Citation: Jm. Pluda et al., ADMINISTRATION OF PENTOSAN POLYSULFATE TO PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSI-SARCOMA, Journal of the National Cancer Institute, 85(19), 1993, pp. 1585-1592
Authors:
GOLDSPIEL BR
KOHLER DR
KOUSTENIS AG
WILSON WH
TOLCHER AW
OSHAUGHNESSY JA
WITTES RE
CHABNER BA
Citation: Br. Goldspiel et al., PACLITAXEL ADMINISTRATION USING PORTABLE INFUSION PUMPS, Journal of clinical oncology, 11(11), 1993, pp. 2287-2288
Authors:
GOLDSPIEL BR
GREEN L
CALIS KA
Citation: Br. Goldspiel et al., HUMAN GENE-THERAPY, Clinical pharmacy, 12(7), 1993, pp. 488-505
Authors:
BENBARUCH N
DENICOFF AM
GOLDSPIEL BR
OSHAUGHNESSY JA
COWAN KH
Citation: N. Benbaruch et al., PHASE-II STUDY OF FAZARABINE (NSC-281272) IN PATIENTS WITH METASTATICCOLON-CANCER, Investigational new drugs, 11(1), 1993, pp. 71-74
Risultati:
1-15
|